4-Fluorobenzamidine, Hydrochloride, Monohydrate
Catalog: |
BB056090 |
Product Name: |
4-Fluorobenzamidine, Hydrochloride, Monohydrate |
Synonyms: |
4-Fluorobenzamidine; 4-FLUORO-BENZAMIDINE; 4-Fluorobenzimidamide; 4-fluorobenzenecarboximidamide; 4-Fluoro-Benzamidine Hcl H2O; Benzenecarboximidamide, 4-fluoro-; 4-Fluorobenzamidine, Hydrochloride, Monohydrate; 4-fluorobenzene-1-carboximidamide |
IUPAC Name: | 4-fluorobenzenecarboximidamide |
Description: | 4-Fluorobenzamidine, Hydrochloride, Monohydrate (cas# 2339-59-5) is a compound useful in organic synthesis. |
Molecular Weight: | 192.61 |
Molecular Formula: | C7H10ClFN2O |
Canonical SMILES: | C1=CC(=CC=C1C(=N)N)F |
InChI: | InChI=1S/C7H7FN2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,(H3,9,10) |
InChI Key: | OSTGTIZRQZOYAH-UHFFFAOYSA-N |
Melting Point: | 213-215°C |
Solubility: | Methanol |
Appearance: | White Solid |
Storage: | -20°C |
GHS Hazard Statement: | H302+H312+H332 (50%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020164004-A1 | Moisture-curable polyolefin formulation | 20190213 |
CA-3129165-A1 | Moisture-curable polyolefin formulation | 20190213 |
CN-113383039-A | Moisture curable polyolefin formulations | 20190213 |
EP-3924419-A1 | Moisture-curable polyolefin formulation | 20190213 |
KR-20210126659-A | Moisture Curable Polyolefin Formulation | 20190213 |
WO-2020028150-A1 | Inhibitors of histone deacetylase useful for the treatment or prevention of hiv infection | 20180801 |
KR-20200007332-A | Pyrimininone derivative compounds and use thereof | 20180712 |
WO-2020013646-A1 | Pyrimidinone derivative compound and use thereof | 20180712 |
KR-102131022-B1 | Pyrimininone derivative compounds and use thereof | 20180712 |
WO-2019158107-A1 | Heterocyclic compound, application thereof and pharmaceutical composition comprising same | 20180214 |
Complexity: | 128 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 138.05932639 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 138.05932639 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 49.9Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS